These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 26575464)

  • 21. Immuno- and genetic therapy in autoimmune diseases.
    Chernajovsky Y; Dreja H; Daly G; Annenkov A; Gould D; Adams G; Croxford JL; Baker D; Podhajcer OL; Mageed RA
    Genes Immun; 2000 Jun; 1(5):295-307. PubMed ID: 11196690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A systematic approach to autoinflammatory syndromes: a spelling booklet for the beginner.
    Rigante D
    Expert Rev Clin Immunol; 2017 Jun; 13(6):571-597. PubMed ID: 28064547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Editorial: Switching to biological agents in autoimmune and autoinflammatory disorders: current targets and therapy.
    Gasparyan AY
    Curr Med Chem; 2015; 22(16):1890-1. PubMed ID: 25693591
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of refractory autoimmune diseases with ablative immunotherapy.
    Cohen Y; Nagler A
    Autoimmun Rev; 2004 Feb; 3(2):21-9. PubMed ID: 15003184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The autoinflammatory side of systemic sclerosis.
    De Santis M; Selmi C
    Isr Med Assoc J; 2015 Jan; 17(1):47-9. PubMed ID: 25739177
    [No Abstract]   [Full Text] [Related]  

  • 26. [Gene therapy in autoimmune rheumatic diseases].
    Sekigawa I; Ogasawara H; Hirose S
    Nihon Rinsho; 1999 Feb; 57(2):449-53. PubMed ID: 10078022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous immunoglobulins in autoimmune and inflammatory diseases: a mechanistic perspective.
    Sibéril S; Elluru S; Graff-Dubois S; Negi VS; Delignat S; Mouthon L; Lacroix-Desmazes S; Kazatchkine MD; Bayry J; Kaveri SV
    Ann N Y Acad Sci; 2007 Sep; 1110():497-506. PubMed ID: 17911465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Efficacy and safety analysis of off-label treatment with biologics in autoinflammatory diseases : Experiences from a German registry (GRAID2)].
    Proft F; Fleck M; Fiehn C; Schulze-Koops H; Witt M; Dörner T; Henes JC
    Z Rheumatol; 2018 Feb; 77(1):46-54. PubMed ID: 28589388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemokine axis as a therapeutic target to enhance the recruitment of Tregs and treat organ-specific autoimmune and inflammatory diseases.
    Bayry J
    Immunotherapy; 2012 Jan; 4(1):9-12. PubMed ID: 22149994
    [No Abstract]   [Full Text] [Related]  

  • 30. The emerging role of interleukin-1β in autoinflammatory diseases.
    Lane T; Lachmann HJ
    Curr Allergy Asthma Rep; 2011 Oct; 11(5):361-8. PubMed ID: 21728024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies.
    Maddur MS; Miossec P; Kaveri SV; Bayry J
    Am J Pathol; 2012 Jul; 181(1):8-18. PubMed ID: 22640807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Biological therapy of arthritis and systemic autoimmune diseases].
    Tamási L; Szekanecz Z
    Orv Hetil; 2007 Apr; 148 Suppl 1():63-70. PubMed ID: 17430797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus.
    Eisenberg R; Albert D
    Nat Clin Pract Rheumatol; 2006 Jan; 2(1):20-7. PubMed ID: 16932648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathogenesis of spondyloarthritis: autoimmune or autoinflammatory?
    Ambarus C; Yeremenko N; Tak PP; Baeten D
    Curr Opin Rheumatol; 2012 Jul; 24(4):351-8. PubMed ID: 22488076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exercise as a therapeutic tool to counteract inflammation and clinical symptoms in autoimmune rheumatic diseases.
    Perandini LA; de Sá-Pinto AL; Roschel H; Benatti FB; Lima FR; Bonfá E; Gualano B
    Autoimmun Rev; 2012 Dec; 12(2):218-24. PubMed ID: 22776785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunotherapy for autoimmune and inflammatory renal diseases.
    Booth AD; Firth JD; Jayne DR
    Expert Opin Biol Ther; 2003 Jun; 3(3):487-500. PubMed ID: 12783617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TNF receptor signalling in autoinflammatory diseases.
    Jarosz-Griffiths HH; Holbrook J; Lara-Reyna S; McDermott MF
    Int Immunol; 2019 Sep; 31(10):639-648. PubMed ID: 30838383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-Inflammatory Effects of Modified Adenoviral Vectors for Gene Therapy: A View through Animal Models Tested.
    Castañeda-Lopez ME; Garza-Veloz I; Lopez-Hernandez Y; Barbosa-Cisneros OY; Martinez-Fierro ML
    Immunol Invest; 2016 Jul; 45(5):450-70. PubMed ID: 27245510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Introduction: mechanisms of tissue injury in autoimmune diseases.
    Eilat D
    Semin Immunopathol; 2014 Sep; 36(5):491-3. PubMed ID: 25168400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autoinflammatory diseases in pediatrics.
    Meiorin SM; Espada G; Rosè C
    Arch Argent Pediatr; 2013 Jun; 111(3):237-43. PubMed ID: 23732351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.